Natasha Giordano
2020
In 2020, Natasha Giordano earned a total compensation of $2.4M as President, Chief Executive Officer and Director at Dipexium Pharmaceuticals, a 51% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $364,375 |
|---|---|
| Option Awards | $1,524,250 |
| Salary | $530,000 |
| Other | $17,953 |
| Total | $2,436,578 |
Giordano received $1.5M in option awards, accounting for 63% of the total pay in 2020.
Giordano also received $364.4K in non-equity incentive plan, $530K in salary and $18K in other compensation.
Rankings
In 2020, Natasha Giordano's compensation ranked 4,673rd out of 13,090 executives tracked by ExecPay. In other words, Giordano earned more than 64.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,673 out of 13,090 | 64th |
Division Manufacturing | 1,898 out of 5,620 | 66th |
Major group Chemicals And Allied Products | 743 out of 2,253 | 67th |
Industry group Drugs | 637 out of 1,953 | 67th |
Industry Pharmaceutical Preparations | 481 out of 1,458 | 67th |
Source: SEC filing on September 29, 2022.
Giordano's colleagues
We found two more compensation records of executives who worked with Natasha Giordano at Dipexium Pharmaceuticals in 2020.